2.84
price down icon7.19%   -0.22
pre-market  Pre-market:  3.00   0.16   +5.63%
loading

Grace Therapeutics Inc Stock (GRCE) Forecast

The Grace Therapeutics Inc (GRCE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $2.84. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GRCE Price Target
Average 0.00 (-100.00% Downside)
loading

Is Grace Therapeutics Inc (GRCE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 31.90 Neutral
STOCH(9,6) 38.31 Neutral
STOCHRSI(14) 44.53 Neutral
MACD(12,26) -0.1317 Sell
ADX(14) 28.59 Sell
William %R -97.77 Buy
CCI(14) -239.77 Sell
Buy: 1 Sell: 3 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
3.3175
Sell
3.24
Sell
MA20
3.3237
Sell
3.3552
Sell
MA50
3.6238
Sell
3.4519
Sell
MA100
2.7909
Buy
0.00
Buy
MA200
1.3955
Buy
0.00
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, GRCE could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 9 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on GRCE, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 31.9 indicates that GRCE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 38.31 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.53 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 28.59 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -239.77 indicates that GRCE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Grace Therapeutics Inc Stock (GRCE) Year by Year Forecast

$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):